Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen-Reference-Cited by-同舟云学术

Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

Published:2003-10-15 Issue:8 Volume:188 Page:1213-1230
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Monath Thomas P.,Guirakhoo Farshad,Nichols Richard,Yoksan Sutee,Schrader Robert,Murphy Chris,Blum Paul,Woodward Stephen,McCarthy Karen,Mathis Danell,Johnson Casey,Bedford Philip

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/188/8/1213/2661734/188-8-1213.pdf

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9–23 months old in Uganda, 2019–2020 — Preliminary report;Vaccine;2024-09

2. Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview;Heliyon;2024-08

3. Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial;The Lancet Infectious Diseases;2024-08

4. YF17D‐based vaccines – standing on the shoulders of a giant;European Journal of Immunology;2024-04-03

5. An immunoinformatics and structural vaccinology approach to design a novel and potent multi-epitope base vaccine targeting Zika virus;BMC Chemistry;2024-02-13